August 27, 2016 6:11 PM ET

Biotechnology

Company Overview of Vascular Pharmaceuticals, Inc.

Company Overview

Vascular Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutics for treating patients with type 1 and type 2 diabetes. It focuses on the development of VPI-2690B, a subcutaneously administered monoclonal antibody that is stimulated by hyperglycemia for the treatment of diabetic nephropathy. The company was founded in 2005 and is based in Research Triangle Park, North Carolina.

79 TW Alexander Drive

Research Commons

Building 4401

Suite 200A

Research Triangle Park, NC 27709

United States

Founded in 2005

Phone:

508-362-3087

Key Executives for Vascular Pharmaceuticals, Inc.

Chief Executive Officer and Director
Co-Founder, Chief Scientific Officer and Director
Co-Founder and Director of Research & Development
Chief Financial Officer
Chief Development Officer and Director
Age: 66
Compensation as of Fiscal Year 2016.

Vascular Pharmaceuticals, Inc. Key Developments

Vascular Pharmaceuticals, Inc. Presents at BIO International Convention 2015, Jun-16-2015 03:00 PM

Vascular Pharmaceuticals, Inc. Presents at BIO International Convention 2015, Jun-16-2015 03:00 PM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States. Speakers: Richard Shea, President and CEO.

Vascular Pharmaceuticals, Inc. Presents at CED Life Science Conference 2015, Mar-04-2015 11:15 AM

Vascular Pharmaceuticals, Inc. Presents at CED Life Science Conference 2015, Mar-04-2015 11:15 AM. Venue: Raleigh Convention Center, Raleigh, North Carolina, United States.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 23, 2015
--
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Vascular Pharmaceuticals, Inc., please visit www.vascularpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.